3-Year Renal Data in Adults with Hypoparathyroidism Treated with TransCon(R) PTH (Palopegteriparatide) to Be Shared at Kidney Week 2025
3-Year Renal Data in Adults with Hypoparathyroidism Treated with TransCon(R) PTH (Palopegteriparatide) to Be Shared at Kidney Week 2025 GlobeNewswire November 03, 2025 COPENHAGEN, Denmark, Nov. 03, 2025 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced that its data showing sustained improvements in renal function, continued normalization of urine calcium handling, and continued […]